Mean (No) | SD | Median | Min | Max | |
---|---|---|---|---|---|
Age (years) | 67.7 | 14.1 | 68.8 | 12 | 88 |
Gender Female (%) | 23 (50) | ||||
Eye right (%) | 27 (59) | ||||
Treatment per eye | 1.2 | 0.5 | 1 | 1 | 3 |
No. of preoperative VFs | 5.5 | 3.3 | 5 | 2 | 14 |
No. of postoperative VFs | 3.6 | 1.7 | 3 | 2 | 8 |
Last preop VF to surgery (days) | 243.4 | 303.0 | 128 | 7 | 1421 |
Surgery to first postop VF (days) | 273.2 | 138.6 | 269 | 16 | 596 |
Retreatment (%) | 20 | ||||
Follow-up preoperative (years) | 3.6 | 2.8 | 3 | 0.2 | 9.9 |
Follow-up postoperative (years) | 2.1 | 1.4 | 1.7 | 0.4 | 5.8 |
IOP preoperative | 23.2 | 4.7 | 23 | 14.4 | 33.2 |
IOP postoperative | 14.3 | 3.2 | 14.1 | 8 | 22 |
No. of AGM preop. | 3 | 1.5 | 3 | 0 | 6 |
No. of AGM postop. | 2.44 | 1.42 | 3 | 0 | 6 |
BCVA preoperative | 0.16 | 0.56 | 0.1 | 2.9 | 0 |
BCVA postoperative | 0.22 | 0.52 | 0.15 | 2.9 | −0.1 |
Phakic at the time of surgery (%) | 23 (50) | ||||
Surgical treatment before FU (%) | 37 (80) | ||||
– Trabeculectomy (%) | 18 (39) | ||||
– ELT (%) | 4 (9) | ||||
– SLT (%) | 3 (6) | ||||
– ALT (%) | 4 (9) | ||||
– Tube shunt (%) | 2 (4) | ||||
– Deep sclerectomy (%) | 5 (11) | ||||
– YAG–laser iridotomy (%) | 1 (2) |